SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responsesWanwisa Dejnirattisai, Malcolm G. Semple, Piyada Supasa et al.|Cell|2022Cited by 1k
Perspectives: SARS-CoV-2 Spike Convergent Evolution as a Guide to Explore Adaptive AdvantageJiří Zahradník, Gideon Schreiber|Frontiers in Cellular and Infection Microbiology|2022Cited by 26